Superworth

Anaptysbio profit margin ANAB

Gross, operating and net profit as a share of revenue over the last twelve months, from 2016.

Net margin, 12 months
n/m
a quarter missing
Peer median
11.1%

Anaptysbio's net margin over the last twelve months can't be worked out yet: a quarter of its results is missing from our data.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2026n/an/a
FY2025−5.6%20.4%
FY2024n/an/a
FY2023n/an/a
FY2022n/an/a
FY2021−91.5%−89.9%
FY2020−26.6%−31.8%
FY2019n/an/a
FY2018n/an/a
FY2017n/an/a
FY2016−25.5%−18.1%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q4 FY26n/an/an/a
Q2 FY26−11.5%n/a17.6%
Q4 FY25−5.6%n/a20.4%
Q3 FY25−49.9%n/a−16.9%
Q2 FY25n/an/a−69.9%
Q1 FY25n/an/a−89.6%
Q4 FY24n/an/an/a
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Anaptysbio's size, closest first, today.

CompanyProfit margin
ANABAnaptysbion/m
PCRXPacira BioSciences2.0%
PAHCPhibro Animal Health6.6%
ANIPANI Pharmaceuticals11.1%
OMEROmerosn/m
AMPHAmphastar Pharmaceuticals10.8%
HRMYHarmony Biosciences18.9%
PBHPrestige Consumer Healthcare15.6%
ABUSArbutus Biopharma84.2%
NRIXNurix Therapeutics42.0%
COLLCollegium Pharmaceutical5.9%
Peer median11.1%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Anaptysbio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.